Targeting the NLRP3 inflammasome in cardiovascular diseases
Authors:
Top Cited Papers
- 1 August 2022
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 236, 108053
Abstract
No abstract availableKeywords
This publication has 271 references indexed in Scilit:
- Activation and regulation of the inflammasomesNature Reviews Immunology, 2013
- Critical role for calcium mobilization in activation of the NLRP3 inflammasomeProceedings of the National Academy of Sciences, 2012
- Regulation of inflammasome signalingNature Immunology, 2012
- The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouseProceedings of the National Academy of Sciences, 2011
- Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasomeCell Death & Disease, 2011
- The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistanceNature Medicine, 2011
- NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsNature, 2010
- Anti-inflammatory Compounds Parthenolide and Bay 11-7082 Are Direct Inhibitors of the InflammasomeJournal of Biological Chemistry, 2010
- Pattern Recognition Receptors and InflammationCell, 2010
- Neutralization of Interleukin-18 Ameliorates Ischemia/Reperfusion-induced Myocardial InjuryJournal of Biological Chemistry, 2009